Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Latest filing published 29 Jul 2026 for Ethos Technologies Inc.. Read the official filing
Filing timeline
BuySaleGV 2019 GP, L.L.C.
Insider track record
Disclosed buys
0
Disclosed sells
19
Signal history
GV 2019 GP, L.L.C.: trading record in brief
GV 2019 GP, L.L.C. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Ethos Technologies Inc., Prime Medicine, Inc. and Verve Therapeutics, Inc. Over a trading history stretching from 21 June 2021 to 28 July 2026, the count stands at 42 filings.
On the market, this insider has only sold: 19 sales, €14.1M in total. In 2026 alone, the filings show no purchases and 12 sales.
The latest filing, published on 29 July 2026, reports a transaction in Ethos Technologies Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to GV 2019 GP, L.L.C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations42 total
196,931 shares0Class A Common StockSEC:0001168404-26-000041:0
118,138 shares0Class A Common StockSEC:0001168404-26-000041:2
196,931 shares@ US$19.46290.12% mcap32.9% of flowClass A Common StockSEC:0001168404-26-000041:1
118,138 shares@ US$18.89960.068% mcap19.2% of flowClass A Common StockSEC:0001168404-26-000041:3
63,297 shares0Class A Common StockSEC:0001168404-26-000039:0
23,417 shares0Class A Common StockSEC:0001168404-26-000039:2
63,297 shares@ US$19.05730.037% mcap10.3% of flowClass A Common StockSEC:0001168404-26-000039:1
23,417 shares@ US$18.87520.013% mcap3.8% of flowClass A Common StockSEC:0001168404-26-000039:3
22,900 shares0Class A Common StockSEC:0001168404-26-000036:0
49,582 shares0Class A Common StockSEC:0001168404-26-000036:3
200 shares@ US$19.720.0001% mcap0.0% of flowClass A Common StockSEC:0001168404-26-000036:2
49,582 shares@ US$19.23010.029% mcap8.2% of flowClass A Common StockSEC:0001168404-26-000036:4
22,700 shares@ US$19.04950.013% mcap3.7% of flowClass A Common StockSEC:0001168404-26-000036:1
20,534 shares0Class A Common StockSEC:0001168404-26-000031:0
18,386 shares0Class A Common StockSEC:0001168404-26-000031:2
20,534 shares@ US$18.68190.012% mcap3.3% of flowClass A Common StockSEC:0001168404-26-000031:1
18,386 shares@ US$18.86540.010% mcap3.0% of flowClass A Common StockSEC:0001168404-26-000031:3
74,492 shares0Class A Common StockSEC:0001168404-26-000029:0
19,595 shares0Class A Common StockSEC:0001168404-26-000029:3
12,500 shares@ US$18.7930.0071% mcap2.0% of flowClass A Common StockSEC:0001168404-26-000029:1
19,595 shares@ US$18.72970.011% mcap3.1% of flowClass A Common StockSEC:0001168404-26-000029:4
61,992 shares@ US$19.83760.037% mcap10.5% of flowClass A Common StockSEC:0001168404-26-000029:2
37,405 shares0Common StockSEC:0001209191-23-039122:0
66,659 shares0Common StockSEC:0001209191-23-038363:0
28,100 shares0Common StockSEC:0001209191-23-037334:0
25 of 42 declarations
